- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
- 10-K Annual report
- 10.5 Amendment No. 3 to Term Loan Agreement
- 10.14 Tandem Diabetes Care, Inc. 2016 Cash Bonus Plan.
- 23.1 Consent of Independent Registered Public Accounting Firm.
- 31.1 Certification of CEO, Pursuant to SECTION?302 of the Sarbanes-oxley Act of 2002.
- 31.2 Certification of CFO, Pursuant to SECTION?302 of the Sarbanes-oxley Act of 2002.
- 32.1 Certification of CEO, Pursuant to U.s.c. SECTION?1350, As Adopted Pursuant to SECTION?906 of the Sarbanes-oxley Act of 2002.
- 32.2 Certification of CFO, Pursuant to U.s.c. SECTION?1350, As Adopted Pursuant to SECTION?906 of the Sarbanes-oxley Act of 2002.
- Download Excel data file
- View Excel data file
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-200686) of Tandem Diabetes Care, Inc.,
(2) Registration Statement (Form S-8 No. 333-192406) pertaining to the 2006 Stock Incentive Plan, 2013 Stock Incentive Plan, and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc., and
(3) Registration Statement (Form S-8 No. 333-202254) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc.;
of our report dated February 24, 2016, with respect to the financial statements of Tandem Diabetes Care, Inc. included in this Annual Report (Form 10-K) of Tandem Diabetes Care, Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP
San Diego, California
February 24 , 2016